VP, Global Medical Lead Respiratory in London

Location: UK – London – New Oxford Street, USA - Pennsylvania - Upper Providence

Date: Jan 27 2026

Job Purpose

The VP, Global Medical Lead (GML) Respiratory is a key senior business leadership role, reporting to the VP Global Medical Affairs, Specialty Care, and is a key member of GSK's Global Medical Affairs, Specialty Care Leadership Team. The GML will have full responsibility for the Global Medical Strategy for the asset. The GML will lead the translation of our science to shape the practice of medicine and specialty care to deliver positive health impact for patients by providing healthcare decision-makers around the world with the evidence and confidence they need on GSK therapies and influencing internal stakeholders with medical insight and expertise related to Development and Commercialization strategies.

The role will be accountable for the Medical strategic direction of the asset and the matrix leadership of the Global Asset Medical Leadership Team, integrating innovative strategies that advance patient care and help shape the practice of medicine. The role will partner with key markets to ensure that their insights are used to inform all evidence, asset/specialty care development and strategic deliverables as well as partnering across Commercial and R&D to deliver value for patients.

In addition to leading the Global Asset Medical Leadership team, the incumbent will be a member of several additional matrix teams including the Medicines/Specialty Care Development Team and the Medicine/Specialty Care Commercial Team where they will provide Medical insight and expertise to inform and influence evidence generation and scientific communication plans across the lifecycle to optimize patient impact within markets.

A key focus of the role is to develop and stretch self and team to be best in industry at delivering impact for patients and improving patient care paradigms.

Key Responsibilities

• Lead both the cross-functional product medical team (PMT) and product development at the Global level.
• As convenor and chair of the PMT.
• Jointly accountable for developing the global medical brand strategy and plans for the asset.
• Set direction along strategic framework of the medical brand plan including setting scientific objectives, owning the medical scientific narrative and the integrated communication plan.
• Accountable for directing and coordinating global resources to generate data and create content to support priority markets, leveraging the expertise of the Global operations team and Global data team.
• Represent medical in cross-functional strategy meetings and workshops, and proactively offer options for innovative medical strategy for the Integrated Asset Plan (IAP) at the Product Development Team (PDT) and Product Commercial Team (PCT) meetings.
• Provide focused support at key inflection points during development (e.g., launch).
• As Lead of PMT and medical product team at Global level.
• Responsible for representing the voice of the Chief Patient Officer (CPO) Organization for the asset.
• Accountable for all medical activities related to product development at the global level.
• Lead, coach, and mentor direct reports that support the PMT in development of medical brand strategy and plans, and execute and/or support execution of global tactics.
• Address broader holistic disease area considerations as they arise by convening other relevant PMLs ad-hoc.

Enterprise Leadership

• Maximize the positive impact for patients and GSK from early development to maturity (defined as no further significant clinical evidence generation).
• Act as a partner to the Development and Commercial Lead, ensure integrated and thoughtful insights from across a diverse stakeholder set contribute to shaping the medicines vision, development strategy and clinical development in the early phases of development, and for refining medical strategy as clinical evidence is generated.
• Ensure that medical insights from the priority markets are incorporated into the PMT to inform all evidence, product development, and asset strategy deliverables.
• Accountable for leading the PMT in the development and delivery of the Global medical product strategy and associated global deliverables enabling prioritized countries to execute the strategy and deliver positive patient impact locally.
• Ensure that the evidence generation plan aligns to identified unmet needs and prioritized evidence gaps and addresses key medical and market access requirements, maximizing the asset competitiveness from launch through lifecycle management for priority markets.

Performance Culture

• Maintains the patient at the center of everything we do.
• Full immersion in the science, disease area and business to be a true and equal partner to R&D, Commercial and Key Local Operating Companies (LOCs).
• Outstanding matrix leadership through the creation of a collaborative and cross-functional environment by fostering shared accountability and responsibility for delivery of specific goals and projects, and encouraging employees to work with diverse skill sets and learn from each other.
• Seek out, actively listen to and understand the needs of key markets and ensure they are appropriately reflected in the global strategy, inclusive of evidence generation and all other deliverables.
• Assess and understands the external environment, inclusive of the competitor landscape, to bring insights together to develop a clear, simple, compelling Medical strategy to improve outcomes for patients.

People

• Be a role model to all GSK employees, setting the right tone from the top while embedding a culture of performance underpinned by GSK Purpose, strategy and culture.
• Visibly leads with authenticity and confidence to gain followship for a workable plan, even in ambiguity.
• Creates cohesion and fellowship amongst the Medical Asset/Portfolio Leadership Team, especially with key/priority LOCs, maximizing its effectiveness as a decision-making unit, external impact and fostering collective accountability for success.
• Communicates consistently and with impact, with the goal that everyone who works on an asset understands and can implement the strategy.
• Adapt approaches for seeking input and feedback to accommodate cultural differences in LOCs.

Qualifications

• Basic: Medical Doctor, Pharmacist or PhD.
• Therapy Area experience/expertise in Respiratory.
• In country experience as a Therapy Area Medical Lead or Country Medical Director.
• Experience directing the strategy of an asset at a global level.
• Experience working in clinical development.
• Expertise in launching an asset at local and global level.
• Asset lifecycle management expertise at local and global level.
• Expertise in Data Generation in terms of asset development.
• Experience of omnichannel strategies.

Preferred

• The role requires good understanding and knowledge of core principles in how to use clinical data, guide strategic use of clinical data, and understand implementation of clinical studies.
• Critical interaction with external experts (physicians) in the therapeutic area - requiring a high level of medical knowledge/experience, understanding of patient management, and strong clinical judgement on benefit-risk significance.
• Keeping up to date on scientific data and competitive intelligence and having the ability to transform knowledge and medical insights into patient-centred strategic thinking and transfer to action plans to drive strategies to win.
• Ability to manage ambiguity, evaluate benefit and risk and take appropriate accountability for decision making - enterprise leader with business acumen and agility to create business outputs in a VUCA (Volatility, Uncertainty, Complexity, Ambiguity) environment.
• Harness cross-functional collaboration and influence various stakeholders across different levels in the matrix organisation.
• Impactful communication and influencing skills with the ability to distil complexity down to what matters most to our stakeholders.
• Strong financial/budget and project management skills as well as business acumen.
• Maintenance of high professional standards and adherence to internal and external codes of practice.